Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 2
|
pp. 1733–1749
Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma
Back to article
Figure 5
(5 of 7)
−
100%
+
Figure 5.
Relationship between methylation levels of CpG sites in the HPSM and FDA drug sensitivity.